IBD-Sleep: A Pilot Study Looking at Changes in Sleep Timing and IBD Symptoms
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Michigan
About this trial
This research study is testing whether changes in sleep timing and morning light treatment may have an impact on symptoms related to inflammatory bowel disease.
Eligibility criteria
Qualifiers
Biopsy-proven IBD
Active IBD symptoms
Impaired IBD quality of life
Age >/=18 years old
Disqualifiers
Ileostomy, colostomy, ileoanal pouch, or ileorectal anastomoses, are planned for imminent surgery and/or have short bowel syndrome
Other significant chronic disease
Retinal pathology, history of eye surgery, taking photosensitizing medications
Recent history of light treatment
Trial design
Treatments tested in this trial
- Morning light treatment
- Treatment-as-usual
Treatment groups
68 Participants
are divided into 2 treatment groupsSponsors and collaborators
University of Michigan
Lead sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborator
Source ClinicalTrials.gov